{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:18:09Z","timestamp":1787840289751,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Fetal growth restriction (FGR) is defined as a pathological decrease in the rate of fetal growth. Neuropilin-1 (NRP1) is a transmembrane glycoprotein, involved in the regulation of angiogenesis, and has emerged as a potential biomarker for various pregnancy-related complications. A recent study showed that NRP1 is downregulated in the placenta of FGR pregnancies. This study aimed to evaluate the role of NRP1 as a prognostic marker in FGR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a case\u2013control study, carried out in the department of obstetrics and gynecology in collaboration with pathology over a period of 1 year. After informed consent and ethical clearance, a total of 200 pregnant women were enrolled. FGR was defined as per Delphi criteria 2016. 100 women who had FGR, were classified into two groups, 37 had severe FGR, 63 had mild FGR, and 100 women who had appropriate for gestational age fetuses were considered controls. 2 ml venous blood sample was withdrawn and maternal serum NRP1 (sNRP1) level was measured by ELISA technique using (Elabscience) ELISA kit as per producer protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Severe FGR was found in 18.5% and mild FGR in 31%. On umbilical artery Doppler, mean pulsatility index (PI) and resistive index (RI) were increased in severe FGR fetuses as compared to mild FGR (PI 2.170 vs. 1.462 and RI 0.723 vs. 0.725). Mean sNRP1 level was high in severe FGR as compared to mild FGR, (1970.84 pg\/ml vs. 1708.31 pg\/ml) while a significant low level of sNRP1 (1080.75 pg\/ml) was found in fetuses of appropriate for gestation age (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2264 0.001). At the cutoff value of sNRP1 &gt;1493 had a sensitivity of 100% and specificity of 96% for prediction of FGR (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Maternal serum sNRP1 has good diagnostic and prognostic value in FGR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aam.aam_289_24","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T01:03:34Z","timestamp":1741741414000},"page":"438-442","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Maternal Serum Neuropilin a Prognostic Marker in Fetal Growth Restriction: A Tertiary Center Experience"],"prefix":"10.4103","volume":"24","author":[{"given":"Rekha","family":"Sachan","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpalata","family":"Sachan","sequence":"additional","affiliation":[{"name":"Department of Physiology, Autonomous State Medical College, Hardoi, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munna Lal","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of General Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahid","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Pathology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"R1-20260423","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1542\/peds.86.5.707","article-title":"Impact of intrauterine growth retardation and body proportionality on fetal and neonatal outcome","volume":"86","author":"Kramer","year":"1990","journal-title":"Pediatrics"},{"key":"R2-20260423","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00003081-200606000-00008","article-title":"Perinatal outcome and later implications of intrauterine growth restriction","volume":"49","author":"Pallotto","year":"2006","journal-title":"Clin Obstet Gynecol"},{"key":"R3-20260423","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1203\/00006450-199511000-00017","article-title":"Growth in full-term small-for-gestational-age infants: From birth to final height","volume":"38","author":"Karlberg","year":"1995","journal-title":"Pediatr Res"},{"key":"R4-20260423","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jama.283.5.625","article-title":"Adult functional outcome of those born small for gestational age: Twenty-six-year follow-up of the 1970 British Birth Cohort","volume":"283","author":"Strauss","year":"2000","journal-title":"JAMA"},{"issue":"Suppl 1","key":"R5-20260423","first-page":"S54","article-title":"Neurodevelopmental outcome of small-for-gestational-age infants","volume":"52","author":"Goldenberg","year":"1998","journal-title":"Eur J Clin Nutr"},{"key":"R6-20260423","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1542\/peds.108.1.111","article-title":"School difficulties in 20-year-olds who were born small for gestational age at term in a regional cohort study","volume":"108","author":"Larroque","year":"2001","journal-title":"Pediatrics"},{"key":"R7-20260423","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajog.2006.01.014","article-title":"Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction","volume":"195","author":"Crispi","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R8-20260423","first-page":"249","article-title":"Impact of intrauterine growth restriction on long-term health","volume":"17","author":"Salam","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R9-20260423","doi-asserted-by":"crossref","first-page":"509.e1","DOI":"10.1016\/j.ajog.2014.05.032","article-title":"Angiogenic and inflammatory biomarkers in midpregnancy and small-for-gestational-age outcomes in Tanzania","volume":"211","author":"Darling","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20260423","doi-asserted-by":"crossref","first-page":"132.e1","DOI":"10.1016\/j.ajog.2013.04.009","article-title":"Maternal soluble fms-like tyrosine kinase-1, placental growth factor, plasminogen activator inhibitor-2, and folate concentrations and early fetal size: The Generation R study","volume":"209","author":"Bouwland-Both","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20260423","doi-asserted-by":"crossref","first-page":"345.e1","DOI":"10.1016\/j.ajog.2013.11.012","article-title":"Angiopoietin 1 and 2 serum concentrations in first trimester of pregnancy as biomarkers of adverse pregnancy outcomes","volume":"210","author":"Schneuer","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R12-20260423","doi-asserted-by":"crossref","first-page":"76","DOI":"10.21276\/obgyn.2020.7.15","article-title":"Prevalence, characteristics and maternal risk factors of small for gestational age fetuses in a tertiary care center from Kerala","volume":"7","author":"Subramanian","year":"2020","journal-title":"New Indian J OBGYN"},{"key":"R13-20260423","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.apjr.2015.12.014","article-title":"Risk factors and adverse perinatal outcome associated with low birth weight in Northern Tanzania: A registry-based retrospective cohort study","volume":"5","author":"Mitao","year":"2016","journal-title":"Asian Pacific J Reprod"},{"key":"R14-20260423","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1161\/01.CIR.103.9.1264","article-title":"Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life","volume":"103","author":"Leeson","year":"2001","journal-title":"Circulation"},{"key":"R15-20260423","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijgo.2004.03.006","article-title":"Chronic hypertension and the risk for adverse pregnancy outcome after superimposed pre-eclampsia","volume":"86","author":"Vanek","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"R16-20260423","doi-asserted-by":"crossref","first-page":"287.e1","DOI":"10.1016\/j.ajog.2013.01.016","article-title":"Maternal plasma concentrations of angiogenic\/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia","volume":"208","author":"Chaiworapongsa","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20260423","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajog.2021.11.1357","article-title":"Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach","volume":"226","author":"Lees","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20260423","doi-asserted-by":"crossref","first-page":"279.e1","DOI":"10.1016\/j.ajog.2015.09.068","article-title":"Down-regulation of placental neuropilin-1 in fetal growth restriction","volume":"214","author":"Maulik","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20260423","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bpobgyn.2004.02.009","article-title":"Perinatal mortality and fetal growth restriction","volume":"18","author":"Kady","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_289_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:19:35Z","timestamp":1787836775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_289_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_289_24","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"2024-12-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}